Cargando…
Predicted Impact of the Model for End-Stage Liver Disease 3.0 in a Region Suffering Severe Organ Shortage
BACKGROUND: The model for end-stage liver disease 3.0 (MELD3.0) is expected to address the flaws of the current allocation system for deceased donor liver transplantation (DDLT). We aimed to validate MELD3.0 in the Korean population where living donor liver transplantation is predominant due to orga...
Autores principales: | Kim, Deok-Gie, Yim, Seung Hyuk, Min, Eun-Ki, Choi, Mun Chae, Lee, Jae Geun, Kim, Myoung Soo, Joo, Dong Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477074/ https://www.ncbi.nlm.nih.gov/pubmed/37667579 http://dx.doi.org/10.3346/jkms.2023.38.e274 |
Ejemplares similares
-
Survival benefit of living-donor liver transplantation in patients with a model for end-stage liver disease over 30 in a region with severe organ shortage: a retrospective cohort study
por: Yim, Seung Hyuk, et al.
Publicado: (2023) -
Risk Factors for Cytomegalovirus Infection and Its Impact on Survival after Living Donor Liver Transplantation in South Korea: A Nested Case-Control Study
por: Yim, Seung Hyuk, et al.
Publicado: (2023) -
Cumulative exposure to tacrolimus during early period after liver transplantation does not affect the recurrence of hepatocellular carcinoma
por: Kim, Deok-Gie, et al.
Publicado: (2023) -
The Effect of Model for End-Stage Liver Disease 3.0 on Disparities between Patients with and without Hepatocellular Carcinoma in Korea
por: Kim, Kunhee, et al.
Publicado: (2023) -
Antiplatelet Drugs on the Recurrence of Hepatocellular Carcinoma after Liver Transplantation
por: Choi, Mun Chae, et al.
Publicado: (2022)